(58) developed a study related to the combined hepatocellular-cholangiocarcinoma (cHC-CC) and found that the effect of ARID1A variations on the clinicopathological significance of cHC-CC might be correlated to oxidative stress and alpha-fetoprotein (AFP)-positivity. Here, ARID1A is linked to cholangiocarcinoma.